Conmed (CNMD) Stock Highlights

70.69 | -1.48%

2024-11-21 02:48:47

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.

Statistics

Range Today

70.27 71.79

Volume Today 262.6K

Range 1 Year

61.05 117.27

Volume 1 Year 117.99M

Range 3 Year

61.05 155.51

Volume 3 Year 302.26M

Range 10 Year

35.51 159.11

Volume 10 Year 677.02M

Highlights

Market Capitalization 2.27B (mid)

Floating Shares 30.62M

Current Price 70.69

Price To Earnings 17.73

Price To Revenue 2.49

Price To Book 2.43

Earnings Per Share 4.22

Dividend Yield 1.07%

Dividend Per Share 0.8

Payout Ratio 18.96%

Performance

Latest -1.48%

1 Month +6.75%

3 Months +3.99%

6 Months -5.27%

1 Year -34.5%

3 Years -50.2%

5 Years -37.29%

10 Years +70.54%

Benchmarks

Market Capitalization

24 / 92

Gross Profits

17 / 85

Total Revenue

17 / 89

Total Rank

57 / 92

Free Cashflow

11 / 90

Performance 5 years

48 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.